Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Because GHK-Cu operates through cumulative signaling rather than peak concentration, researchers commonly build in an escalation: a lower dose in the first half of a cycle, a higher dose in the second half, followed by a deliberate rest period before starting again
BPC-157 is not specifically named on the WADA Prohibited List as a separately listed substance, but as a non-approved substance with no marketing authorization it may fall under WADA section S0 (Non-Approved Substances), which prohibits substances not addressed by other sections of the List that have no current approval for human therapeutic use
ABAD directly links Abeta to mitochondrial toxicity in Alzheimers disease
If your 100mg vial costs $80-150 (common retail range): At 1mg daily: $0.80-1.50 per dose At 2mg daily: $1.60-3.00 per dose At 3mg daily: $2.40-4.50 per dose At 5mg daily: $4.00-7.50 per dose Compared to clinic-administered GHK-Cu treatments costing $50-200+ per session, self-administered research protocols offer substantial cost advantages
